Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
YONKERS, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...
50% of cutaneous T-cell lymphoma patients treated with 300mg IV infusion achieved objective response ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email